Fisher Wallace Laboratories - Employees, Business, Industry & CEO

Fisher Wallace Laboratories was founded in 2007.

Fisher Wallace Laboratories headquarters are in 630 Flushing Ave, Brooklyn, New York 11206, US.

Fisher Wallace Laboratories has 13 employees.

Fisher Wallace Laboratories is in Medical Device sector.

Fisher Wallace Labs is on a mission to vastly increase access to mental healthcare. We develop and commercialize wearable brain stimulation technology for the treatment of depression, anxiety, and other neuropsychiatric and cognitive disorders. Our technology was recently proven to be rapidly effective in two large clinical trials for the treatment of Major Depressive Disorder and Generalized Anxiety Disorder, the latter of which was conducted in collaboration with the Seattle Police Department and Washington State University. Previous research includes a successful pilot study conducted at Beth Israel Hospital for the treatment of Bipolar II Depression, and a substance use rehabilitation study conducted at Phoenix House. Under temporary FDA clearance, we distributed 100,000 Version 1.0 devices through 14,000 prescribers, generating $40 million in revenue, and obtained Medicaid reimbursement in Maine (MaineCare). We are currently engaged in obtaining regulatory approval for OAK, our Version 2.0 technology, designed in collaboration with the teams behind Beats and Nest, with the goal of commercializing in 2025 and ultimately achieving smartphone scale.

We are not able to find any specialities related to Fisher Wallace Laboratories at the moment.

We do not have the information about the CEO of Fisher Wallace Laboratories. Our systems are trying to find it, we will update it as soon as we have it.